NP, C., K, H., P, P., V, R., H, H., & D, M. (2016). Ranibizumab in neovascular age-related macular degeneration: A 5-year follow-up. Dove Medical Press.
Cita Chicago Style (17a ed.)NP, Cvetkova, Hölldobler K, Prahs P, Radeck V, Helbig H, y Märker D. Ranibizumab in Neovascular Age-related Macular Degeneration: A 5-year Follow-up. Dove Medical Press, 2016.
Cita MLA (8a ed.)NP, Cvetkova, et al. Ranibizumab in Neovascular Age-related Macular Degeneration: A 5-year Follow-up. Dove Medical Press, 2016.
Precaución: Estas citas no son 100% exactas.